Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
We prescribe medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) or compounded versions when clinically appropriate
Oral GLP-1s cause weight loss, and for Alzheimer's patients who are already at increased risk of frailty that weight loss includes dangerous muscle mass loss
doi: 10.1038/s41598-019-38877-0 5 AlbornozK.ZhouJ.YuJ.BecklesD
Sold as Mounjaro (for diabetes) and Zepbound (for weight management), tirzepatide has quickly become the most prescribed alternative for people who want more weight loss than semaglutide delivers
:max_bytes(150000):strip_icc()/health-WIWIK-glp1-amanda-69851454e91f461e85f009c94296b9a9.jpg)
Over-loss and muscle pooled SURMOUNT, BMI below 22 reached by about 7% (as early as week 12), toward about 15% by week 88 in the longest trial, clinical underweight under 0.4% (Almandoz 2026)
US$ 26.45
US$ 24.28
US$ 25.16
